Atlas Trials

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Clinical trial NCT00322231 · COMPLETED

Trial details

NCT number
NCT00322231
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2006-05-01
Primary completion
2007-07-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.